Latest Breaking News On - Pathogen genomic laboratory - Page 1 : comparemela.com

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death. The National Institute of Allergy andA clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death. The National Institute of Allergy and » The FINANCIAL Featured

United statesNew yorkDemocratic republic of the congoJean jacques muyembe tamfumPlacide mbalaAnthonys fauciUs centers for diseaseUs department of healthHuman servicesNational institute of allergyWorld health organizationDrug administrationUs national institutes of healthEpidemiology departmentInstitute of tropical medicine antwerpPathogen genomic laboratory